Clinical Report: Evaluating a Multidisciplinary Approach to Preoperative Management
Overview
This study evaluates the effectiveness of a structured Lung Cancer Pathway (LCP) over seven years, demonstrating significant reductions in the time from pathway initiation to clinical record closure. The findings indicate improvements in workflow efficiency and multidisciplinary coordination in lung cancer care.
Background
The management of lung cancer requires a multidisciplinary approach to optimize patient outcomes and streamline care processes. Structured clinical pathways, such as the Lung Cancer Pathway (LCP), are designed to enhance diagnostic evaluations and treatment strategies while minimizing delays. This study assesses the impact of the LCP on patient management and surgical readiness over a seven-year period.
Data Highlights
Year
Median Length of LCP (days)
Median Interval to Surgery (days)
2018
9 (IQR 2–23)
29 (IQR 15–43)
2024
1 (IQR 0–8)
35 (IQR 23–43)
Key Findings
The median length of the LCP decreased significantly from 9 days in 2018 to 1 day in 2024 (p < 0.001).
The median interval from LCP closure to surgery increased from 29 days in 2018 to 35 days in 2024 (p = 0.013).
A total of 2,691 patients were analyzed during the study period.
16.6% of patients did not undergo surgery after multidisciplinary evaluation due to various factors.
Temporal trends indicated a significant improvement in workflow efficiency over the study period (p < 0.001).
Clinical Implications
The findings suggest that implementing a structured LCP can enhance the efficiency of preoperative management in lung cancer patients. Healthcare providers may consider adopting similar multidisciplinary approaches to improve coordination and reduce delays in patient care.
Conclusion
The structured Lung Cancer Pathway has shown to improve the efficiency of diagnostic and decision-making processes in lung cancer care over seven years. These results highlight the potential benefits of organized multidisciplinary pathways in thoracic oncology.
